OM Outset Medical
- 2.380
- -0.170-6.67%
- 2.300
- -0.080-3.36%
Outset Medical News
RBC Capital Sticks to Its Hold Rating for Outset Medical (OM)
Outset Medical Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Outset Medical (OM), Exact Sciences (EXAS) and DarioHealth (DRIO)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Crispr Therapeutics AG (CRSP), Alcon (ALC) and Outset Medical (OM)
Outset Medical Downgraded at RBC Citing a Difficult 2024
RBC Capital Downgrades Outset Medical to Sector Perform, Lowers Price Target to $6
Outset Medical Analyst Ratings
Outset Medical Analyst Ratings
Outset Medical's Stable Growth and Financial Consistency: A Buy Rating Recommendation
Morgan Stanley Maintains Equal-Weight on Outset Medical, Lowers Price Target to $5
Outset Medical Analyst Ratings
RBC Capital Reaffirms Their Buy Rating on Outset Medical (OM)
Analysts Conflicted on These Healthcare Names: Ascend Wellness Holdings LLC (OtherAAWH), Vertex Pharmaceuticals (VRTX) and Outset Medical (OM)
TD Cowen Reaffirms Their Buy Rating on Outset Medical (OM)
TD Cowen Cuts Outset Medical Price Target to $9 From $32, Maintains Outperform Rating
B of A Securities Downgrades Outset Medical to Underperform, Lowers Price Target to $3
Outset Tumbles ~40% After Bofa Downgrades Following Guidance Cut
Outset Medical Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Nurix Therapeutics (NRIX), Prothena (PRTA) and Outset Medical (OM)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Celldex (CLDX), Outset Medical (OM) and Annovis Bio (ANVS)
Analysis
Price Target
No Data
